Moreover, as previously described, high-levels of HOOK3 predicts worse prognosis in prostate cancer [26], but it is still unclear the mechanistic role of HOOK3 in regulating cancer progression and drug resistance. This evidence concerns the gene HOOK3 and Familial prostate cancer.